Aura Biosciences Reports Second Quarter 2023 Financial Results and Provides Clinical Development and Operational Highlights marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.
Strengthened Clinical and Regulatory Leadership Team with Key AppointmentsStart-up Activities for the Global Phase 3 Trial Ongoing with Release of Drug Product Manufactured with Commercial Process and First Patient Expected to be Dosed in 2H 2023BOSTON (BUSINESS WIRE) Aura Biosciences Inc. (NASDAQ: AURA), a clinic.